Fig. 3From: Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged societyStratified analysis for all-cause mortality (a) and HF readmission (b) in the propensity-matched cohort. AF, atrial fibrillation or atrial flutter; CAD, coronary artery disease; CI, confidence interval; DPP4, dipeptidyl peptidase-4; HF, heart failure; SGLT2, sodium-glucose cotransporter-2Back to article page